Page 14 - Avidity Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Immunome Surges On News Of Merger With Morphimmune

Shares of biopharmaceutical company Immunome, Inc. (IMNM) are rising more than 36% Thursday morning after announcing merger with Morphimmune, a private biotechnology company in an all-stock transaction.

Clayb siegallRedmile groupImmunome incEnavate sciencesTargeted effector platformDiscovery engineMorphimmune presidentJanus henderson investorsAvidity partnersWoodline partners

Aledade Rakes in $260M for Primary Care Network

Aledade's $260 million financing round was led by Lightspeed Venture Partners, a new investor of the company. It also included participation from Venrock, Avidity Partners, OMERS Growth Equity and Fidelity Management and Research Company.

District of columbiaUnited statesGalym imanbayevFarzad mostashariCarefirst bluecross blueshieldMedicare shared savings programAgilon healthResearch companyMedicare advantageLightspeed venture partnersAvidity partnersFidelity managementVenture partnersCarefirst bluecrossOak street health

Value-based care company Aledade garners $260M

The company also added two new members to its board of directors and a new senior vice president for Medicare Advantage.

United statesFarzad mostashariDavid blumenthalPaul hennessyAledade care solutionsFidelity management research companyUnited healthcare medicare solutionsCommonwealth fundVenture partnersAvidity partnersFidelity managementUnited states national coordinatorHealth information technologyEfrem castilloNew york basedIris healthcare

Bethesda s Aledade just closed a $260M Series F

With the funds, the healthtech company will be looking to expand its provider networks and upgrade its tech. This is the fourth year in a row the company has raised an over $50 million round.

Galym imanbayevFarzad mostashariMedicare shared savings programResearch companyVenture partnersAvidity partnersOmers growth equityFidelity managementMedicare advantage

Health-Care Startup Aledade Valued at $3 5 Billion After Fundraise

Health-Care Startup Aledade Valued at $3 5 Billion After Fundraise
bloomberg.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bloomberg.com Daily Mail and Mail on Sunday newspapers.

Fidelity management research coLightspeed venture partnersAvidity partnersFidelity management